BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30905446)

  • 1. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.
    Zhang M; Dou H; Yang D; Shan M; Li X; Hao C; Zhang Y; Zeng P; He Y; Liu Y; Fu J; Wang W; Hu M; Li H; Tian Q; Lei S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():141-163. PubMed ID: 30905446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.
    Tang Y; Cui Y; Zhang S; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():121-140. PubMed ID: 30905445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA153 as biomarker for cancer and noncancer diseases.
    Li X; Xu Y; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CA199 levels are significantly increased in patients suffering from liver, lung, and other diseases.
    Zeng P; Li H; Chen Y; Pei H; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():253-264. PubMed ID: 30905455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population.
    Chen XZ; Zhang WK; Yang K; Wang LL; Liu J; Wang L; Hu JK; Zhang B; Chen ZX; Chen JP; Zhou ZG; Mo XM
    Mol Biol Rep; 2012 Sep; 39(9):9031-9. PubMed ID: 22752725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases.
    He Y; Lu H; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():199-212. PubMed ID: 30905450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum CA724 levels in patients suffering gout vs cancers.
    Zhang Y; Zhang M; Bai X; Li C; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():177-186. PubMed ID: 30905448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
    Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
    Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CEA levels in 49 different types of cancer and noncancer diseases.
    Hao C; Zhang G; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():213-227. PubMed ID: 30905451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA242 as a biomarker for pancreatic cancer and other diseases.
    Dou H; Sun G; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():229-239. PubMed ID: 30905452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers.
    Zhang M; Zhang Y; Fu J; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():241-252. PubMed ID: 30905453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum SCCA levels in patients suffering cancers or other diseases.
    Yang D; Wang J; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():165-175. PubMed ID: 30905447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum CA50 levels in patients with cancers and other diseases.
    Shan M; Tian Q; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():187-198. PubMed ID: 30905449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
    Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
    J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS
    Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.
    Luo G; Liu C; Guo M; Cheng H; Lu Y; Jin K; Liu L; Long J; Xu J; Lu R; Ni Q; Yu X
    Ann Surg; 2017 Apr; 265(4):800-805. PubMed ID: 28267695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification and characterization of novel N-glycan-based biomarkers in gastric cancer.
    Liu L; Yan B; Huang J; Gu Q; Wang L; Fang M; Jiao J; Yue X
    PLoS One; 2013; 8(10):e77821. PubMed ID: 24147084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
    Zhao H; Chen W; Wu J; Wang L; Mao W
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer].
    Wu G; Ba J; Wang E; Teng Y; Fan X
    Zhongguo Fei Ai Za Zhi; 2004 Feb; 7(1):35-7. PubMed ID: 21211189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.